When Dennis Carr learned he had early Alzheimer’s disease, he immediately thought of his older brother who had died of the ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

Eli Lilly's Kisunla (donanemab) has been approved in Japan for early symptomatic Alzheimer's, including mild cognitive ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...

Eli Lilly’s (NYSE:LLY) treatment for early Alzheimer's disease has been approved for use in Japan. Kisunla (donanemab-azbt), ...

The Dutch company has created a device for the early detection of Alzheimer’s disease, and it is on its way to developing ...

A diagnosis in the early stages may allow you to start treatments that can slow disease progression.

Blocking calcium channels in brain capillaries may enhance blood flow and alleviate early-stage Alzheimer's damage, new study ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said its Kisunla for the treatment of adults with early symptomatic Alzheimer's disease has been approved by the Ministry of Health, Labour and Welfare ...

Penn State Extension is offering a Healthy Living Brain and Body Educational workshop on Oct. 1 from 4-5 p.m. at the Friendship Community Library 127 Main St. Beech Creek, PA 16822 To register, ...